Nonprescription Drug Innovation Act (H.R.9774); dietary supplements; Generally Recognized as Safe (GRAS); Over the Counter Monograph User Fee Act (OMUFA); Generally Recognized as Safe and Effective (GRASE); HR.10336-Dietary Supplement Innovation Act; issues related to Rx to OTC Switch/PDUFA reauthorization.
2026 · 3rd Quarter (July 1 - Sep 30)
CHATTEM, INC D/B/A OPELLA
Filed by CHATTEM, INC D/B/A OPELLA.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 6, 2026
- Income
- Not reported
- Expenses
- $180,000.00
- Registrant
- CHATTEM, INC D/B/A OPELLA
- Filing UUID
- 5d309b33-2cce-4cc4-b6e5-12caeb9a4e5f
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Tariffs.
Illicit sale of OTCs on online retailer platforms.
H.R.1219-To amend the Internal Revenue Code of 1986 to include over-the-counter oral healthcare products as qualified medical expenses which can be purchased with HSA and FSA funds.
Literal federal measure citations: H.R.1219
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.